CLDX

Celldex Therapeutics (CLDX)

About Celldex Therapeutics (CLDX)

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Details

Daily high

$25.94

Daily low

$25.02

Price at open

$25.18

52 Week High

$53.18

52 Week Low

$22.93

Market cap

1.7B

Dividend yield

0.00%

Volume

2.2M

Avg. volume

1.1M

P/E ratio

-9.79

Celldex Therapeutics News